ArticleBritish journal of cancer2009
Human papillomavirus infection in Beijing, People's Republic of China: a population-based study.
Article in British journal of cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.Oral and maxillofacial surgery · 2014Pooled it
- Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China.BioMed research international · 2018Trial
- Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China.Scientific reports · 2016Trial
- Comprehensive Analysis of Codon Usage Bias in Human Papillomavirus Type 51.Polish journal of microbiology · 2024Article
- Human papillomavirus distribution and cervical cancer epidemiological characteristics in rural population of Xinjiang, China.Chinese medical journal · 2021Article
- Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012-2018: baseline measures prior to mass HPV vaccination.BMC infectious diseases · 2021Article
- Cross-neutralizing antibody titres against non-vaccine types induced by a recombinant trivalent HPV vaccine (16/18/58) in rhesus macaques.Papillomavirus research (Amsterdam, Netherlands) · 2020Article
- Prevalence of human papillomavirus infection and type distribution among Uyghur females in Xinjiang, northwest China.Oncology letters · 2020Article
- Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.Virology journal · 2020Article
- Characteristics of human papillomaviruses distribution in Guizhou Province, China.Virology journal · 2019Article
- Prevalence and Determinants of High-risk HPV Infection among 11549 Women from an Opportunistic Screening in Hubei Province.Current medical science · 2019Article
- Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2019Article
- Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.Virology journal · 2019Article
- Influencing Factors of High-Risk Human Papillomavirus Infection and DNA Load According to the Severity of Cervical Lesions in Female Coal Mine Workers of China.Journal of Cancer · 2019Article
- Single-cell whole-genome sequencing identifies human papillomavirus integration in cervical tumour cells prior to and following radiotherapy.Oncology letters · 2018Article
- Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.BMC cancer · 2018Article
- Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.Experimental and therapeutic medicine · 2018Article
- Epidemiology of Humanpapilloma virus infection among women in Fujian, China.BMC public health · 2017Article
- High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.Journal of gynecologic oncology · 2017Article
- Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.Human vaccines & immunotherapeutics · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNo recent data exist on human papillomavirus (HPV) infection in Beijing, People's Republic of China. MATERIALS AND
methodWe interviewed and examined a representative, randomly selected sample of 5552 sexually active women aged 25-54 years. Cervical cell samples were analysed for HPV DNA by a MY09/11-based PCR assay.
resultsHuman papillomavirus prevalence was 6.7% overall and 4.8% among women without cervical abnormalities. Of the 21 subtypes identified, HPV16 was the commonest type (2.6% overall; 39.1% of HPV-positive women), followed by HPV 58 (1.0%), 33 (0.8%), 43 (0.7%) and 56 (0.7%). High-risk HPV types predominated in all age groups. Human papillomavirus prevalence was highest in young to middle-aged women. Marital status, number of husband's sexual partners, age at sexual debut and nulligravidity were all associated with being HPV positive.
conclusionsIn our survey, HPV 16, HPV 58 and HPV 33 were the most prevalent HPV types in Beijing, indicating the potential for the prophylactic HPV 16/18 vaccine in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.